Oxidative stress in psychiatric disorders: evidence base and therapeutic implications
How Weight Loss Drugs Went Mainstream These medications (particularly Ozempic, Wegovy, and Mounjaro) quickly gained attention after celebrities began using them for cosmetic weight loss
Current batch I7392 99.82% Tested April 2026 View Certificate of Analysis Batch I7392 Customer Reviews No reviews yet Be the first to review this product
Andy Cohen Reveals GLP-1 Weight Loss Journey Andy Cohen is getting something off his chest
Neuroprotective effects of lixisenatide and liraglutide in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease
Mechanism of Action Comparison# Retatrutide# Retatrutide (LY3437943) is a 39-amino acid peptide that simultaneously activates three metabolically important receptors: GLP-1 receptor : Enhances glucose-dependent insulin secretion, suppresses glucagon release, slows gastric emptying, and promotes central satiety signaling GIP receptor : Potentiates insulin secretion, may improve beta-cell function, and contributes to adipose tissue metabolism Glucagon receptor : Increases hepatic glucose output acutely but chronically promotes hepatic fat oxidation, thermogenesis, and energy expenditure The glucagon receptor component distinguishes retatrutide from all other approved or late-stage metabolic peptides